NL-OMON45251
尚未招募
不适用
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and its metastases - CTC Autopsy study
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- lungcancer
- 发起方
- niversitair Medisch Centrum Groningen
- 入组人数
- 50
- 状态
- 尚未招募
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\. Patients with a histologically/cytologically proven lung cancer.
- •2\. Patients have to have a non\-curable disease state, without curative treatment options
- •3\. Signed informed consent of patient
- •4\. Patients family has asserted their acceptance of the patients participation
排除标准
- 未提供
结局指标
主要结局
未指定
相似试验
Unknown
不适用
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and metastasesSCLC niet kleincellig longcarcinoom, longkankerlungcancer, tumour heterogeneity, tumor heterogeniteit, CTC, circulating tumour cell, circulerende tumor celNL-OMON29203niversity Medical Centre Groningen30
招募中
不适用
Characterisation of tumour heterogeneity and identification of adaptive resistance mechanisms of metastatic castration-resistant prostate carcinomaC61Malignant neoplasm of prostateDRKS00028021Klinik für Nuklearmedizin am Universitätsklinikum Augsburg45
尚未招募
1/2 期
Tumour heterogeneity studies based on dedicated breast PET using proliferation radiotracers: early detection of the treatment response.2024-512152-38-00Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela100
尚未招募
不适用
Fluorodeoxyglucose (FDG) and human epidermal growth factor receptor 2 (HER2) positron emission tomography (PET) scan in breast cancerBreast cancerCancer - BreastACTRN12624000918527Fiona Stanley Hospital10
招募中
不适用
Value of 7 Tesla in gliomasHigh grade and low grade gliomaNL-OMON24352Medical Delta25